NO920331D0 - Biologisk preparat samt bruk derav - Google Patents

Biologisk preparat samt bruk derav

Info

Publication number
NO920331D0
NO920331D0 NO920331A NO920331A NO920331D0 NO 920331 D0 NO920331 D0 NO 920331D0 NO 920331 A NO920331 A NO 920331A NO 920331 A NO920331 A NO 920331A NO 920331 D0 NO920331 D0 NO 920331D0
Authority
NO
Norway
Prior art keywords
biological preparation
antigenic
relates
material derived
treatment against
Prior art date
Application number
NO920331A
Other languages
English (en)
Other versions
NO920331L (no
Inventor
John Lawson Standford
Graham Arthur William Rook
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Publication of NO920331L publication Critical patent/NO920331L/no
Publication of NO920331D0 publication Critical patent/NO920331D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Thin Film Transistor (AREA)
  • Recrystallisation Techniques (AREA)
NO920331A 1989-07-28 1992-01-24 Biologisk preparat samt bruk derav NO920331D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898917256A GB8917256D0 (en) 1989-07-28 1989-07-28 Biological preparation and its use
PCT/GB1990/001169 WO1991001751A1 (en) 1989-07-28 1990-07-27 Biological preparation and its use

Publications (2)

Publication Number Publication Date
NO920331L NO920331L (no) 1992-01-24
NO920331D0 true NO920331D0 (no) 1992-01-24

Family

ID=10660759

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920331A NO920331D0 (no) 1989-07-28 1992-01-24 Biologisk preparat samt bruk derav

Country Status (13)

Country Link
EP (1) EP0484438B1 (no)
JP (1) JPH05500803A (no)
AT (1) ATE136467T1 (no)
AU (1) AU644376B2 (no)
CA (1) CA2064029C (no)
DE (1) DE69026506T2 (no)
DK (1) DK0484438T3 (no)
ES (1) ES2088431T3 (no)
FI (1) FI920356A0 (no)
GB (1) GB8917256D0 (no)
NO (1) NO920331D0 (no)
WO (1) WO1991001751A1 (no)
ZA (1) ZA905927B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
WO1992008488A1 (en) * 1990-11-08 1992-05-29 University College London Mycobacterium as adjuvant for antigens
GB9024320D0 (en) * 1990-11-08 1990-12-19 Univ London Treatment of uveitis
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
GB9903539D0 (en) 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
US8110204B2 (en) * 2001-01-17 2012-02-07 Cadila Pharmaceuticals Ltd. Method of treating human-immunodeficiency virus (HIV) disease infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
DE3728367C1 (de) * 1987-08-25 1988-09-01 Burkhard Steglich Mittel zur Immunisierung des menschlichen Koerpers bei HIV-Infektionen

Also Published As

Publication number Publication date
WO1991001751A1 (en) 1991-02-21
NO920331L (no) 1992-01-24
GB8917256D0 (en) 1989-09-13
CA2064029C (en) 1998-12-29
ATE136467T1 (de) 1996-04-15
JPH05500803A (ja) 1993-02-18
ES2088431T3 (es) 1996-08-16
DE69026506T2 (de) 1996-09-12
DE69026506D1 (de) 1996-05-15
ZA905927B (en) 1991-05-29
CA2064029A1 (en) 1991-01-29
AU6188390A (en) 1991-03-11
DK0484438T3 (da) 1996-06-10
AU644376B2 (en) 1993-12-09
EP0484438B1 (en) 1996-04-10
FI920356A7 (fi) 1992-01-27
EP0484438A1 (en) 1992-05-13
FI920356A0 (fi) 1992-01-27

Similar Documents

Publication Publication Date Title
DK0556241T3 (da) Mycobacterium vaccae til behandling af uveitis
NL300404I1 (en) Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens
FI920356A0 (fi) En biologisk preparation samt dess anvaendning.
DE69309915D1 (de) Mycobacterium Vaccae zur Behandlung von langwierigen Autoimmunerkrankungen
BR9303762A (pt) Uso de material antigenico e/ou imunorregulatorio derivado de mycobacterium vaccae,processo para o tratamento de infeccao por hiv com ou sem aids,produtos e agente imunoterapeutico
NO900009L (no) Fremgangsmaate for fremstilling av aspiringranuler med regulert frigivningseffekt.
MX9100808A (es) Antigenos superficiales inmunodominantes de la entomoeba histolitica.
ATE92763T1 (de) Mittel zur behandlung des parkinson-syndroms.